Ocular Therapeutix OCUL Business Segments — Investment Income Net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's business segments — investment income net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's business segments — investment income net?
- Ocular Therapeutix (OCUL) reported business segments — investment income net of $6.05M in Q1 2026.
- How has Ocular Therapeutix's business segments — investment income net changed year-over-year?
- Ocular Therapeutix's business segments — investment income net increased by 58.1% year-over-year, from $3.83M to $6.05M.
- What is the long-term trend for Ocular Therapeutix's business segments — investment income net?
- Over 3 years (2022 to 2025), Ocular Therapeutix's business segments — investment income net has grown at a 37.7% compound annual growth rate (CAGR), from -$7.02M to $18.35M.
- What does business segments — investment income net mean?
- This represents the net earnings generated from the company's cash, cash equivalents, and marketable securities held within its primary business operations. It reflects the yield on the company's treasury management and liquidity position. A positive trend indicates effective utilization of excess capital to generate supplemental returns.